Design of potent and selective cathepsin K inhibitors which span the active site.

被引:0
|
作者
Thompson, SK
Halbert, SM
Michaud, E
Bossard, MJ
Tomaszek, TA
Levy, MA
Meek, TD
Zhao, B
Smith, WW
Janson, CA
McQueney, MS
AbdelMeguid, SS
Briand, J
Sarkar, SK
Huddleston, MJ
Ijames, CF
Carr, SA
DesJarlais, RL
Shu, A
Garnes, K
Heys, JR
Zembryki, D
LeeRykaczewski, LV
James, IE
Lark, M
Bradbeer, JN
Drake, FH
Gowen, M
Veber, DF
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,DEPT MED CHEM,KING OF PRUSSIA,PA 19406
[2] SMITHKLINE BEECHAM PHARMACEUT,DEPT MOL RECOGNIT,KING OF PRUSSIA,PA 19406
[3] SMITHKLINE BEECHAM PHARMACEUT,DEPT MACROMOL SCI,KING OF PRUSSIA,PA 19406
[4] SMITHKLINE BEECHAM PHARMACEUT,DEPT PHYS & STRUCT CHEM,KING OF PRUSSIA,PA 19406
[5] SMITHKLINE BEECHAM PHARMACEUT,DEPT RADIOCHEM,KING OF PRUSSIA,PA 19406
[6] SMITHKLINE BEECHAM PHARMACEUT,DEPT CELLULAR BIOCHEM,KING OF PRUSSIA,PA 19406
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:279 / MEDI
页数:1
相关论文
共 50 条
  • [1] Design of potent and selective human cathepsin K inhibitors that span the active site
    Thompson, SK
    Halbert, SM
    Bossard, MJ
    Tomaszek, TA
    Levy, MA
    Zhao, BG
    Smith, WW
    Abdel-Meguid, SS
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    Amegadzie, BY
    Hanning, CR
    DesJarlais, RL
    Briand, J
    Sarkar, SK
    Huddleston, MJ
    Ijames, CF
    Carr, SA
    Garnes, KT
    Shu, A
    Heys, JR
    Bradbeer, J
    Zembryki, D
    Lee-Rykaczewski, L
    James, IE
    Lark, MW
    Drake, FH
    Gowen, M
    Gleason, JG
    Veber, DF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) : 14249 - 14254
  • [2] Structure and design of potent and selective cathepsin K inhibitors
    Yamashita, DS
    Smith, WW
    Zhao, BG
    Janson, CA
    Tomaszek, TA
    Bossard, MJ
    Levy, MA
    Oh, HJ
    Carr, TJ
    Thompson, SK
    Ijames, CF
    Carr, SA
    McQueney, M
    DAlessio, KJ
    Amegadzie, BY
    Hanning, CR
    AbdelMeguid, S
    DesJarlais, RL
    Gleason, JG
    Veber, DF
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (46) : 11351 - 11352
  • [3] Potent and selective cathepsin K inhibitors
    Shinozuka, Tsuyoshi
    Shimada, Kousei
    Matsui, Satoshi
    Yamane, Takahiro
    Ama, Mayumi
    Fukuda, Takeshi
    Taki, Motohiko
    Takeda, Yuko
    Otsuka, Eri
    Yamato, Michiko
    Mochizuki, Shin-ichi
    Ohhata, Keiko
    Naito, Satoru
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (20) : 6789 - 6806
  • [4] Thiosemicarbazones as potent and selective cathepsin K inhibitors
    Chavarria, Gustavo E.
    Devanna, Kishore K. Gaddale
    Jones, Lindsay M.
    MacDonough, Matthew T.
    Yoo, Grace K.
    Locke, Ashleigh
    Deliz, Rafael
    Chaplin, David J.
    Siim, Bronwyn G.
    Chen, Shen-En
    Pinney, Kevin G.
    Trawick, Mary L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [5] Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin K
    Tavares, FX
    Boncek, V
    Deaton, DN
    Hassell, AM
    Long, ST
    Miller, AB
    Payne, AA
    Miller, LR
    Shewchuk, LM
    Wells-Knecht, K
    Willard, DH
    Wright, LL
    Zhou, HQ
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) : 588 - 599
  • [6] Design and synthesis of potent and selective inhibitors of the osteoclast-specific cysteine protease, cathepsin K
    Veber, DF
    Marquis, RW
    Ru, Y
    Yamashita, DS
    Oh, HJ
    Thompson, SK
    Halbert, SM
    Carr, TJ
    Gleason, JG
    Tomaszek, TA
    Levy, MA
    Bossard, M
    Tew, DG
    James, IE
    Briand, J
    Carr, SA
    Zymbryki, D
    Lee-Rykaczewski, L
    Desjarlais, RL
    McQueney, MS
    D'Alessio, KJ
    Zhao, B
    Janson, CA
    Abdel-Meguid, SS
    Smith, WW
    PEPTIDE SCIENCE - PRESENT AND FUTURE, 1999, : 628 - 630
  • [7] Rational design of potent and selective NH-linked aryl/heteroaryl cathepsin K inhibitors
    Robichaud, J
    Bayly, C
    Oballa, R
    Prasit, P
    Mellon, C
    Falgueyret, JP
    Percival, MD
    Wesolowski, G
    Rodan, SB
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (16) : 4291 - 4295
  • [8] The use of selective inhibitors for computer modeling of monoamine oxidases active site.
    Veselovsky, AV
    Ivanov, AS
    Medvedev, AE
    VOPROSY MEDITSINSKOI KHIMII, 1997, 43 (06): : 527 - 536
  • [9] The consequences of lysosomotropism on the design of selective cathepsin K inhibitors
    Black, W. Cameron
    Percival, M. David
    CHEMBIOCHEM, 2006, 7 (10) : 1525 - 1535
  • [10] Cathepsin K and the design of inhibitors of cathepsin K
    Yamashita, DS
    Dodds, RA
    CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (01) : 1 - 24